ArticleBioengineering (Basel, Switzerland)2026
Platelet-Rich Plasma (PRP) Assessment in Degenerative Discovertebral Complexes (DVC) Using Quantitative MRI at 4.7T: A Preliminary Animal In Vivo Study.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This exploratory in vivo study investigated the therapeutic potential of intradiscal platelet-rich plasma (PRP) in a rat model of degenerative disc disease (DDD) using quantitative 4.7-T MRI and histologic correlation. Eight female Sprague-Dawley rats underwent induction of disc-vertebral complex degeneration through combined mechanical injury and type I collagenase injection. Immediately thereafter, a single intradiscal injection of leukocyte-poor PRP was administered. Longitudinal MRI evaluation included 3D ultrashort echo time (UTE) imaging, T1 mapping, and T2 mapping at baseline and during follow-up. In untreated discs, degeneration was associated with progressive decreases in nucleus pulposus T1 and T2 values and increased annulus fibrosus T2 values, reflecting dehydration and structural disorganization. In contrast, PRP-treated discs showed relative preservation of nucleus pulposus T1 and T2 relaxation times, while annulus fibrosus T2 values remained more stable, suggesting attenuation of degenerative changes. UTE-derived signal changes were less discriminatory between treated and untreated groups. Histologic analysis confirmed severe nucleus pulposus and annulus fibrosus disorganization in untreated discs, whereas PRP-treated discs demonstrated milder alterations with preserved vertebral endplate architecture. Overall, these preliminary findings suggest that the longitudinal effect of a treatment through intradiscal PRP is feasible and this injection may modulate early degenerative changes in the current animal model. However, the results should be interpreted with caution because of the exploratory design, the aggressive animal degeneration model, the absence of a sham-injection comparator group, and the small number of animals studied.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.